In-vitro antimycobacterial drug susceptibility testing of non-tubercular mycobacteria by tetrazolium microplate assay
Open Access
- 11 July 2008
- journal article
- research article
- Published by Springer Nature in Annals of Clinical Microbiology and Antimicrobials
- Vol. 7 (1) , 15
Abstract
Background: Non-tubercular mycobacteria (NTM) has not been given due attention till the recent epidemic of HIV. This has led to increasing interest of health care workers in their biology, epidemiology and drug resistance. However, timely detection and drug susceptibility profiling of NTM isolates are always difficult in resource poor settings like India. Furthermore, no standardized methodology or guidelines are available to reproduce the results with clinical concordance.Objective: To find an alternative and rapid method for performing the drug susceptibility assay in a resource limited settings like India, we intended to evaluate the utility of Tetrazolium microplate assay (TEMA) in comparison with proportion method for reporting the drug resistance in clinical isolates of NTM.Methods: A total of fifty-five NTM isolates were tested for susceptibility against Streptomycin, Rifampicin, Ethambutol, Ciprofloxacin, Ofloxacin, Azithromycin, and Clarithromycin by TEMA and the results were compared with agar proportion method (APM).Results: Of the 55 isolates, 23 (41.8%) were sensitive to all the drugs and the remaining 32 (58.2%) were resistant to at least one drug. TEMA had very good concordance with APM except with minor discrepancies. Susceptibility results were obtained in the median of 5 to 9 days by TEMA. The NTM isolates were highly sensitive against Ofloxacin (98.18% sensitive) and Ciprofloxacin (90.09% sensitive).M. mucogenicumwas sensitive only to Clarithromycin and resistant to all the other drugs tested. The concordance between TEMA and APM ranged between 96.4 – 100%.Conclusion: Tetrazolium Microplate Assay is a rapid and highly reproducible method. However, it must be performed only in tertiary level Mycobacteriology laboratories with proper bio-safety conditions.Keywords
This publication has 21 references indexed in Scilit:
- Prevalence of mycobacteremia in Indian HIV-infected patients detected by the MB/BacT automated culture systemEuropean Journal of Clinical Microbiology & Infectious Diseases, 2008
- Novel method for clearing red blood cell debris from BacT/ALERT® blood culture medium for improved microscopic and antimycobacterial drug susceptibility test resultsJournal of Clinical Laboratory Analysis, 2007
- Intrinsic Macrolide Resistance in Rapidly Growing MycobacteriaAntimicrobial Agents and Chemotherapy, 2006
- Genes Required for Intrinsic Multidrug Resistance in Mycobacterium aviumAntimicrobial Agents and Chemotherapy, 2004
- Management of opportunist mycobacterial infections: Joint Tuberculosis Committee guidelines 1999Thorax, 2000
- Incidence of Mycobacterium avium-intracellulare Complex Bacteremia in Human Immunodeficiency Virus-Positive PatientsThe Journal of Infectious Diseases, 1992
- MIC as a quantitative measurement of the susceptibility of Mycobacterium avium strains to seven antituberculosis drugsAntimicrobial Agents and Chemotherapy, 1988
- Pulmonary Infection with Nontuberculous MycobacteriaAmerican Review of Respiratory Disease, 1988
- Determination of ansamycin MICs for Mycobacterium avium complex in liquid medium by radiometric and conventional methodsAntimicrobial Agents and Chemotherapy, 1985
- Use of the bactec system for drug susceptibility testing of Mycobacterium tuberculosis, M. kansasii, and M. avium complexDiagnostic Microbiology and Infectious Disease, 1985